Augmedics announced today that it launched new, FDA-cleared features and indications for its Xvision Spine System. Updates to Xvision come just weeks after the company hit its 3,000-patient milestone for the system. It marks Xvision’s largest expansion since its commercial launch. Chicago-based Augmedics said in a news release that the launch creates a technical foundation […]
FDA clears Abbott’s blood test for concussion
Abbott (NYSE:ABT) announced that it received FDA clearance for the first commercially available laboratory traumatic brain injury (TBI) blood test. The test, now widely available to U.S. hospitals, runs on the Abbott Alinity i laboratory instrument. It provides clinicians with an objective way to quickly assess mild TBIs, otherwise known as concussions. Abbott said in […]
DeviceTalks Boston early-bird rate expires tomorrow
The early-bird registration discount for DeviceTalks Boston ends tomorrow, March 9. Register right away to save $300 off (43%) off the full price to attend the May 10-11 event at the Boston Convention & Exhibition Center. Discussions will focus on engineering new devices, materials and manufacturing, bringing products to market, and other challenges to medical […]
The biggest cardiology tech stories from ACC.23
Major medtech players presented a range of intriguing studies at a gathering of some of the biggest names in the cardiology tech space. Some of the hottest topics were covered this past week at the American College of Cardiology’s Annual Scientific Session Together With the World Congress of Cardiology (ACC.23/WCC) in New Orleans. Ablation, cardiac […]
Organ preservation tech developer Paragonix raises $24M series B
Paragonix Technologies announced today that it secured $24 million in a Series B financing round. Cambridge, Massachusetts-based Paragonix plans to use the funds to bolster its commercial footprint. That includes the ongoing extension of its clinical service offerings and inventory expansion. The company also plans to use funds to further advance its organ transplant innovations. […]
Biosense Webster marks first cases with dual energy ablation tech
Biosense Webster today announced the first cases with its investigational Thermocool SmartTouch SF dual energy catheter for treating AFib. The system enables doctors performing an ablation to toggle between two types of energy: pulsed-field and radiofrequency. It appears to be the Johnson & Johnson MedTech subsidiary’s answer to the dual energy ablation tech coming out […]
Zimmer Biomet unveils enhancements to ZBEdge platform
Zimmer Biomet (NYSE:ZBH) plans to unveil more AI integration and other enhancements to its ZBEdge Dynamic Intelligence platform for hip and knee surgeries. The improvements include greater integration of ZB’s WalkAI — artificial intelligence that can predict which patients will have lower gait speed 90 days after hip or knee surgery. Warsaw, Indiana–based Zimmer Biomet […]
Analysts receive update on Embecta insulin patch pump progress
BTIG analysts Marie Thibault and Sam Eiber met with Embecta (Nasdaq:EMBC) executives last week and received an update on the company’s current position. Thibault and Eiber met with Embecta CFO Jake Elguicze and Head of Investor Relations Pravesh Khandelwal. Among a series of updates, the BTIG report said Embecta expects a “transitional period” in the […]
RxSight stock rises on Street-beating Q4
RxSight (Nasdaq:RXST) shares ticked up today on fourth-quarter results that came in ahead of the consensus forecast. Shares of RXST rose 1.1% at $15.85 apiece in mid-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — dipped 0.4%. The Aliso Viejo, California-based ophthalmic medical device maker […]
Orthofix hits 5,000 mark for Fitbone implantations
Orthofix Medical (Nasdaq:OFIX) announced today that it surpassed 5,000 device implants for its Fitbone TAA intramedullary limb-lengthening system. Lewisville, Texas-based Orthofix said the system features more than 20 years of clinical history. Over that time, the device demonstrated safety and effectiveness in limb lengthening and deformity correction in adults and children. Orthofix acquired the Fitbone […]
Nevro fully launches HFX iQ spinal cord stimulation
Nevro (NYSE:NVRO) announced today that it initiated the full U.S. market launch for its HFX iQ spinal cord stimulation (SCS) system. Redwood City, California–based Nevro designed HFX iQ for treating chronic pain. The company commenced its full launch after it completed a successful limited market release. In a news release, Dr. Usman Latif called HFX […]